Coverage
1 story on the Regulatory beat — every filing on this desk, newest first.
Standard BioTools Inc. received a formal warning from Nasdaq on July 22, 2026, after its shares traded below $1.00 for 30 consecutive business days. The Boston-based company, which lists its common stock on the Nasdaq Global Select Market u